Insulin stimulates phosphorylation of the forkhead transcription factor FKHR on serine 253 through a

J Nakae1, B C Park, D Accili

  • 1Developmental Endocrinology Branch, NICHD, National Institutes of Health, Bethesda, Maryland 20892, USA.

Insights

Mutations in the Daf-2 gene cause developmental arrest in C. elegans, but Daf-16 gene mutations counteract this effect. FKHR phosphorylation by insulin suggests it is a key player in insulin signaling pathways.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cell Signaling

Background:

  • Mutations in the insulin/insulin-like growth factor-1 receptor homologue Daf-2 gene in C. elegans lead to developmental arrest.
  • The Daf-16 gene, encoding a forkhead transcription factor, counteracts Daf-2 mutations, indicating its role in Daf-2 signaling.
  • FKHR genes are mammalian homologues of Daf-16, and FKHR proteins have potential phosphorylation sites for Akt kinase.

Purpose of the Study:

  • To investigate whether insulin affects the phosphorylation of FKHR.
  • To determine if PI 3-kinase activity and specific Akt phosphorylation sites are involved in insulin-mediated FKHR phosphorylation.

Main Methods:

  • Studied endogenous FKHR and recombinant c-Myc/FKHR fusion protein phosphorylation in murine hepatocytes.
  • Utilized wortmannin treatment to assess the role of PI 3-kinase.
  • Mutated specific Akt phosphorylation sites (Serine 253, Threonine 24, Serine 316) on FKHR to evaluate their impact on insulin-induced phosphorylation.

Main Results:

  • Insulin stimulated the phosphorylation of both endogenous and recombinant FKHR.
  • Insulin-induced FKHR phosphorylation was inhibited by wortmannin, indicating PI 3-kinase dependence.
  • Mutation of Serine 253 abolished insulin-induced FKHR phosphorylation, while mutations at Threonine 24 and Serine 316 did not.

Conclusions:

  • FKHR phosphorylation is regulated by insulin in a PI 3-kinase-dependent manner.
  • Serine 253 is a critical site for insulin-induced FKHR phosphorylation.
  • FKHR may function as a downstream effector in insulin signaling pathways.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...